(12:35 GMT) Jazz Pharmaceuticals Price Target Cut to $254.00/Share From $256.00 by Truist Securities
Dow Jones Newswires
Jazz Pharmaceuticals Is Maintained at Buy by Truist Securities
- Sources
- Dow Jones Newswires
- Active symbols
- NASDAQ:JAZZ
- Language
- English (India)